Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(ophthalmalgia)
24 results
  • Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes. [Case Reports]
  • IMInt Med Case Rep J 2016; 9:113-6
  • Hayashi Y, Toshida H, … Ohta T
  • CONCLUSIONS: This is the first report about efficacy of rebamipide unit dose 2% ophthalmic suspension for presenting persistent corneal epithelial defect in a patient with diabetes. In the present case, the suggested mechanisms are the following: improving the corneal barrier function, stabilization of mucin on the keratoconjunctival epithelium, and improving the wettability and stability of the tear film, which resulted in the promotion of healing of the corneal epithelial defect in a short time period.
  • [Infection post Excimer Laser Corneal Refractive Surgery]. [Case Reports]
  • NGNippon Ganka Gakkai Zasshi 2015; 119(12):855-62
  • Hieda O, Sotozono C, … Kinoshita S
  • CONCLUSIONS: In the treatment of severe corneal infection post refractive surgery, it is important to identify the primary causative organism. If the response to the initial treatment is poor, such patients should immediately be referred to a special clinic to obtain a better visual outcome.
New Search Next